CPC
CCXI

Consolidated Planning Corp’s ChemoCentryx, Inc. CCXI Stock Holding History

Consolidated Planning Corp’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-40
Closed -$1K – 496
2021
Q3 		$1K Buy
+40
New +$623 ﹤0.01% 442

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Consolidated Planning Corp's CCXI Position: Q4 2021 in Review

Consolidated Planning Corp sold out of ChemoCentryx, Inc. (CCXI) in Q4 2021, closing a stake of 40 shares — an estimated $1K sold.

Consolidated Planning Corp first reported a position in CCXI in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 190 funds tracked by Wall St. Rank hold CCXI as of Q4 2021.

  • Consolidated Planning Corp reported no remaining ChemoCentryx, Inc. position as of Q4 2021 after selling out during the quarter.
  • Consolidated Planning Corp sold 40 ChemoCentryx, Inc. shares in Q4 2021, an estimated $1K.
  • Consolidated Planning Corp first reported a position in ChemoCentryx, Inc. in Q3 2021 and held it in 1 quarter.
  • Consolidated Planning Corp's ChemoCentryx, Inc. position peaked at $1K in Q3 2021.
  • 190 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2021.

Based on Consolidated Planning Corp's 13F filing for Q4 2021, filed 11 Feb 2022.